HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mixed Connective Tissue Disease and Papillary Thyroid Cancer: A Case Report.

AbstractBACKGROUND:
Mixed connective tissue disease (MCTD) is a connective tissue disorder characterized by high titers of distinct antibodies: U1 ribonucleoprotein with clinical features seen in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), dermatomyositis (DM), polymyositis, and scleroderma. The association of SLE and DM with various cancers of the thyroid has been reported in the literature. However, there have been no reports associating MCTD with thyroid cancer.
CASE REPORT:
We present a 58-year-old woman diagnosed with MCTD with co-morbid interstitial lung disease that has remained stable for 10 years, who developed papillary thyroid carcinoma (PTC) 10 years after initial diagnosis.
CONCLUSIONS:
We theorize that: 1) MCTD may have been a primary diagnosis complicated by PTC, or 2) MCTD may have been an initial presentation of paraneoplastic syndrome of silent PTC, because her symptoms of MCTD significantly improved after total thyroidectomy. To the best of our knowledge, this is the first case report to associate MCTD with PTC. It highlights the importance of maintaining a high index of suspicion for thyroid malignancy in MCTD patients.
AuthorsSupat Thongpooswan, Rachel Tushabe, Jeffrey Song, Paul Kim, Adriana Abrudescu
JournalThe American journal of case reports (Am J Case Rep) Vol. 16 Pg. 517-9 (Aug 06 2015) ISSN: 1941-5923 [Electronic] United States
PMID26245523 (Publication Type: Case Reports, Journal Article)
Topics
  • Carcinoma (complications, diagnosis, therapy)
  • Carcinoma, Papillary
  • Female
  • Humans
  • Middle Aged
  • Mixed Connective Tissue Disease (complications, diagnosis, therapy)
  • Thyroid Cancer, Papillary
  • Thyroid Neoplasms (complications, diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: